Vioxx
Celebrex
Bextra
COX-2 Inhibitors
Crestor
Neurontin
Zyprexa
Ephedra
Strattera
Remicade
Accutane
Serzone
Serevent
Tamoxifen
Baycol
Fen Phen
Rezulin
Meridia
PPA
Propulsid
Avara
Permax
Anti-Depressants
OxyContin
Tysabri
Pemoline
 
Guidant Defibrillators
Guidant Ancure Device
Sulzer Hip Replacement
Contraceptive Devices
Breast Implants
 
Welding Rods
Asbestos
Mesothelioma
Lead Poisoning
Silica
 
Cerebral Palsy
Erb's Palsy
Birth Injury
Surgical Mistake
Cancer Misdiagnosis
Nursing Home Negligence
Hospital Negligence
 
Car Accidents
Plane Accidents
Boat Accidents
Bus Accidents
Motorcycle Acc
Brain Injury
Spinal Cord Injury
Dodge Truck and SUV Recall
 
Insurance Bad Faith
Slip and Fall
Dog Bite Injury
Inadequate Security
Recall Forum
Consumer Pro
Sexual Abuse
Product Liability
General Inquiries

Resources

Network

Peers

Serevent Information

    Serevent®, a prescription asthma drug, was approved in 1994 for the treatment of asthma and prevention of bronchospasms in patients 12 years of age and older.

    In recent testimony before the Senate advisory hearing on Vioxx, David Graham, an FDA scientist, raised concerns about asthma side effects and deaths in Serevent® patients. According to the USA Today article by Rita Rubin, "The GlaxoSmithKline asthma drug...dilates breathing passages." In essence, the active ingredient seems to be capable of causing an asthma attack in some patients.

 



    In 2003, Serevent began carrying a "black box" warning label regarding the results of a large U.S. study that indicates a small but significant increase in asthma-related deaths in Serevent patients.

    Serevent® and Advair® asthma medications are under scrutiny by the FDA.




Please share your opinion with us.
Your name:
Your email:
How dangerious do you think this is?:
Write a review for this product:

Copyright 2006 LawsuitResources.com